TYK Medicines Funding: $154M Raised, Series D (2023)

TYK Medicines funding overview

TYK Medicines is based in Huzhou, China. TYK Medicines has raised $154M in total disclosed funding. That places its disclosed total in the $100M–$250M range. Its most recent disclosed round is a Series D announced in December 2023. The round record for TYK Medicines runs through 2023; nothing later has been disclosed. Investors on record include Sichuan Huiyu Pharmaceutical, Yida China Holdings, Guohai Innovation Capital Investment Management. 3 distinct backers are named across the disclosed rounds.

TYK Medicines at a glance

Total raised: $154M
Latest round: Series D
Latest round date: December 2023
Headquarters: Huzhou, China
Notable investors: Sichuan Huiyu Pharmaceutical, Yida China Holdings, Guohai Innovation Capital Investment Management

Frequently asked about TYK Medicines funding

How much has TYK Medicines raised?: TYK Medicines has raised $154M in total disclosed funding across the rounds on record.
Who has invested in TYK Medicines?: Sichuan Huiyu Pharmaceutical, Yida China Holdings, Guohai Innovation Capital Investment Management are named among the investors backing TYK Medicines.
What was the latest TYK Medicines funding round?: The most recent disclosed round is a Series D, announced in December 2023.
Where is TYK Medicines based?: TYK Medicines is based in Huzhou, China.
When did TYK Medicines last raise?: The last disclosed TYK Medicines round closed in December 2023 at Series D.

TYK Medicines totals reflect disclosed capital only — undisclosed extensions and secondaries are excluded. Use the related companies in Huzhou below to benchmark round size and investor mix.

TYK Medicines Funding: $154M Raised, Series D (2023)

TYK Medicines funding overview

TYK Medicines at a glance

Frequently asked about TYK Medicines funding

Companies related to TYK Medicines (36)

Browse related funding lists (3)